Budesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x 10 capsul...
FDA Drug Recall #D-452-2013 — Class III — May 15, 2013
Recall Summary
| Recall Number | D-452-2013 |
| Classification | Class III — Low risk |
| Date Initiated | May 15, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) |
| Location | Rockford, IL |
| Product Type | Drugs |
| Quantity | 1,621 boxes |
Product Description
Budesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x 10 capsules blister packaged) per box, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505; Packaged and Distributed by: UDL Laboratories, Inc., Rockford, IL 61103, NDC 51079-020-03.
Reason for Recall
Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.
Distribution Pattern
Nationwide
Lot / Code Information
Lot No: 3037382, Exp 09/13
Other Recalls from Mylan Institutional, Inc. (d.b.a. UDL...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0861-2022 | Class II | Esomeprazole Magnesium Delayed-Release Capsules... | Apr 1, 2022 |
| D-0860-2022 | Class II | Esomeprazole Magnesium Delayed-Release Capsules... | Apr 1, 2022 |
| D-1013-2019 | Class II | Alprazolam Tablets, USP, 0.25 mg, 10x10 per car... | Jan 18, 2019 |
| D-1112-2018 | Class III | Diltiazem HCl Extended-release Capsules, USP 12... | Aug 14, 2018 |
| D-0822-2018 | Class II | Loxapine Capsules, USP 25 mg, packaged in 100 U... | May 1, 2018 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.